ProPhase Labs, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
ProPhase Labs, Inc. (PRPH) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $375.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-19
- ProPhase Labs, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $375.00K, a 26.18% decline year-over-year.
- ProPhase Labs, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $390.00K, a 25.14% decline year-over-year.
- ProPhase Labs, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $433.00K, a 29.82% decline year-over-year.
- ProPhase Labs, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $431.00K, a 32.23% decline year-over-year.
- ProPhase Labs, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $1.89M, a 47.97% decline from fiscal 2024.
- ProPhase Labs, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $3.64M, a 20.22% decline from fiscal 2023.
- ProPhase Labs, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $4.56M, a 14.40% increase from fiscal 2022.
- ProPhase Labs, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $3.99M, a 25.23% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $375.00K 10-Q · filed 2026-08-19 | $765.00K 10-Q · filed 2026-08-19 | $1.20M derived: sum of 3 quarters · filed 2026-08-19 | $1.63M derived: sum of 4 quarters · filed 2026-08-19 |
| 2026-03-31 | $390.00K 10-Q/A · filed 2026-07-09 | $823.00K derived: sum of 2 quarters · filed 2026-07-09 | $1.25M derived: sum of 3 quarters · filed 2026-07-09 | $1.76M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | $433.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01 | $864.00K derived: sum of 2 quarters · filed 2026-06-01 | $1.37M derived: sum of 3 quarters · filed 2026-08-19 | $1.89M 10-K · filed 2026-06-01 |
| 2025-09-30 | $431.00K 10-Q · filed 2025-11-19 | $939.00K derived: sum of 2 quarters · filed 2026-08-19 | $1.46M 10-Q · filed 2025-11-19 | $2.08M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $508.00K 10-Q · filed 2026-08-19 | $1.03M 10-Q · filed 2026-08-19 | $1.65M derived: sum of 3 quarters · filed 2026-08-19 | $2.28M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | $521.00K 10-Q/A · filed 2026-07-09 | $1.14M derived: sum of 2 quarters · filed 2026-07-09 | $1.77M derived: sum of 3 quarters · filed 2026-07-09 | $2.57M derived: sum of 4 quarters · filed 2026-07-09 |
| 2024-12-31 | $617.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01 | $1.25M derived: sum of 2 quarters · filed 2026-06-01 | $2.05M derived: sum of 3 quarters · filed 2026-06-01 | $3.64M 10-K · filed 2026-06-01 |
| 2024-09-30 | $636.00K 10-Q · filed 2025-11-19 | $1.43M derived: sum of 2 quarters · filed 2025-11-19 | $3.02M 10-Q · filed 2025-11-19 | $3.58M derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-06-30 | $796.00K 10-Q · filed 2025-08-13 | $2.38M 10-Q · filed 2025-08-13 | $2.95M derived: sum of 3 quarters · filed 2025-08-13 | $3.69M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $1.59M 10-Q · filed 2025-05-20 | $2.15M derived: sum of 2 quarters · filed 2025-05-20 | $2.90M derived: sum of 3 quarters · filed 2025-05-20 | $5.20M derived: sum of 4 quarters · filed 2025-05-20 |
| 2023-12-31 | $562.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | $1.31M derived: sum of 2 quarters · filed 2025-04-01 | $3.61M derived: sum of 3 quarters · filed 2025-04-01 | $4.56M 10-K · filed 2025-04-01 |
| 2023-09-30 | $744.00K 10-Q · filed 2024-11-13 | $3.05M derived: sum of 2 quarters · filed 2024-11-13 | $4.00M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $2.31M 10-Q · filed 2024-08-14 | $3.25M 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $947.00K 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | $3.99M 10-K · filed 2024-03-29 | |||
| 2022-06-30 | $528.00K 10-Q · filed 2022-08-12 | $1.01M 10-Q · filed 2022-08-12 | ||
| 2022-03-31 | $482.00K 10-Q · filed 2022-05-13 | |||
| 2021-12-31 | $3.18M 10-K · filed 2023-03-29 | |||
| 2021-06-30 | $1.08M 10-Q · filed 2022-08-12 | $1.50M 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $428.00K 10-Q · filed 2022-05-13 | |||
| 2019-09-30 | $180.00K 10-Q · filed 2019-11-12 | $360.00K derived: sum of 2 quarters · filed 2019-11-12 | $556.00K 10-Q · filed 2019-11-12 | $757.00K derived: sum of 4 quarters · filed 2019-11-12 |
| 2019-06-30 | $180.00K 10-Q · filed 2019-08-12 | $376.00K 10-Q · filed 2019-08-12 | $577.00K derived: sum of 3 quarters · filed 2019-08-12 | $776.00K derived: sum of 4 quarters · filed 2019-11-12 |
| 2019-03-31 | $196.00K 10-Q · filed 2019-05-14 | $397.00K derived: sum of 2 quarters · filed 2019-05-14 | $596.00K derived: sum of 3 quarters · filed 2019-11-12 | $799.00K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-12-31 | $201.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $400.00K derived: sum of 2 quarters · filed 2019-11-12 | $603.00K derived: sum of 3 quarters · filed 2019-11-12 | $634.00K 10-K · filed 2019-03-26 |
| 2018-09-30 | $199.00K 10-Q · filed 2019-11-12 | $402.00K derived: sum of 2 quarters · filed 2019-11-12 | $433.00K 10-Q · filed 2019-11-12 | $465.00K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $203.00K 10-Q · filed 2019-08-12 | $234.00K 10-Q · filed 2019-08-12 | $266.00K derived: sum of 3 quarters · filed 2019-08-12 | $294.00K derived: sum of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | $31.00K 10-Q · filed 2019-05-14 | $63.00K derived: sum of 2 quarters · filed 2019-05-14 | $91.00K derived: sum of 3 quarters · filed 2019-05-14 | |
| 2017-12-31 | $32.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2019-03-26 | $60.00K derived: sum of 2 quarters · filed 2019-03-26 | $78.00K 10-K · filed 2019-03-26 | |
| 2017-09-30 | $28.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2018-08-20 | $46.00K 10-Q/A · filed 2018-08-20 | ||
| 2017-06-30 | $18.00K 10-Q/A · filed 2018-08-20 | |||
| 2016-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-08-20 | $0.00 derived: sum of 2 quarters · filed 2018-08-20 | $0.00 derived: sum of 3 quarters · filed 2018-08-20 | $1.00K 10-K/A · filed 2018-08-20 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $1.00K 10-Q · filed 2016-11-14 | $35.00K derived: sum of 4 quarters · filed 2018-08-20 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $1.00K 10-Q · filed 2016-08-11 | $35.00K derived: sum of 3 quarters · filed 2018-08-20 | $68.00K derived: sum of 4 quarters · filed 2018-08-20 |
| 2016-03-31 | $1.00K 10-Q · filed 2016-05-13 | $35.00K derived: sum of 2 quarters · filed 2018-08-20 | $68.00K derived: sum of 3 quarters · filed 2018-08-20 | $102.00K derived: sum of 4 quarters · filed 2018-08-20 |
| 2015-12-31 | $34.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-08-20 | $67.00K derived: sum of 2 quarters · filed 2018-08-20 | $101.00K derived: sum of 3 quarters · filed 2018-08-20 | $135.00K 10-K/A · filed 2018-08-20 |
| 2015-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $67.00K derived: sum of 2 quarters · filed 2015-11-13 | $101.00K 10-Q · filed 2015-11-13 | $382.00K derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-06-30 | $34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $68.00K 10-Q · filed 2015-08-12 | $349.00K derived: sum of 3 quarters · filed 2017-02-24 | $412.00K derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-03-31 | $34.00K 10-Q · filed 2015-05-13 | $315.00K derived: sum of 2 quarters · filed 2017-02-24 | $378.00K derived: sum of 3 quarters · filed 2017-02-24 | $442.00K derived: sum of 4 quarters · filed 2017-02-24 |
| 2014-12-31 | $281.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $344.00K derived: sum of 2 quarters · filed 2017-02-24 | $408.00K derived: sum of 3 quarters · filed 2017-02-24 | $472.00K 10-K · filed 2017-02-24 |
| 2014-09-30 | $63.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $127.00K derived: sum of 2 quarters · filed 2014-11-13 | $191.00K 10-Q · filed 2014-11-13 | $232.00K derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-06-30 | $64.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $128.00K 10-Q · filed 2014-08-12 | $169.00K derived: sum of 3 quarters · filed 2016-03-29 | $209.00K derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-03-31 | $64.00K 10-Q · filed 2014-05-12 | $105.00K derived: sum of 2 quarters · filed 2016-03-29 | $145.00K derived: sum of 3 quarters · filed 2016-03-29 | $185.00K derived: sum of 4 quarters · filed 2016-03-29 |
| 2013-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $81.00K derived: sum of 2 quarters · filed 2016-03-29 | $121.00K derived: sum of 3 quarters · filed 2016-03-29 | $160.00K 10-K · filed 2016-03-29 |
| 2013-09-30 | $40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $80.00K derived: sum of 2 quarters · filed 2013-11-13 | $119.00K 10-Q · filed 2013-11-13 | $157.00K derived: sum of 4 quarters · filed 2015-03-27 |
| 2013-06-30 | $40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | $79.00K 10-Q · filed 2013-08-13 | $117.00K derived: sum of 3 quarters · filed 2015-03-27 | $156.00K derived: sum of 4 quarters · filed 2015-03-27 |
| 2013-03-31 | $39.00K 10-Q · filed 2013-05-10 | $77.00K derived: sum of 2 quarters · filed 2015-03-27 | $116.00K derived: sum of 3 quarters · filed 2015-03-27 | $154.00K derived: sum of 4 quarters · filed 2015-03-27 |
| 2012-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $77.00K derived: sum of 2 quarters · filed 2015-03-27 | $115.00K derived: sum of 3 quarters · filed 2015-03-27 | $153.00K 10-K · filed 2015-03-27 |
| 2012-09-30 | $39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $77.00K derived: sum of 2 quarters · filed 2012-11-14 | $115.00K 10-Q · filed 2012-11-14 | $152.00K derived: sum of 4 quarters · filed 2014-03-27 |
| 2012-06-30 | $38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | $76.00K 10-Q · filed 2012-08-13 | $113.00K derived: sum of 3 quarters · filed 2014-03-27 | $147.00K derived: sum of 4 quarters · filed 2014-03-27 |
| 2012-03-31 | $38.00K 10-Q · filed 2012-05-11 | $75.00K derived: sum of 2 quarters · filed 2014-03-27 | $109.00K derived: sum of 3 quarters · filed 2014-03-27 | |
| 2011-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $71.00K derived: sum of 2 quarters · filed 2014-03-27 | $131.00K 10-K · filed 2014-03-27 | |
| 2011-09-30 | $34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $94.00K 10-Q · filed 2011-11-14 | ||
| 2011-06-30 | $60.00K 10-Q · filed 2011-08-12 | |||
| 2010-12-31 | $42.00K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |